✦ LIBER ✦

Screening for bladder cancer: a perspective

✍ Scribed by Yair Lotan; Robert S. Svatek; Núria Malats

Book ID: 106033179
Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 237 KB
Volume: 26
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-007-0223-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bladder cancer etiology: A different per

Bladder cancer etiology: A different perspective

✍ David M. Weinberg; Ronald K. Ross; Thomas M. Mack; Annlia Paganini-Hill; Brian E 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

Is there a rationale for bladder cancer

Is there a rationale for bladder cancer screening?

✍ Robert S. Svatek; Yair Lotan 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 168 KB

Introduction: Perspectives in bladder ca

Introduction: Perspectives in bladder cancer

✍ Derek Raghavan 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

Effective Screening for Bowel Cancer: A

Effective Screening for Bowel Cancer: A United Kingdom Perspective

✍ Michael R. Thompson; Robert J. C. Steele; W. S. Atkin 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 298 KB

Chemoradiotherapy as a bladder-preservat

Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: current status and perspectives

✍ Yoshiteru Sumiyoshi 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 165 KB

Evaluation of DNA flow cytometry as a sc

Evaluation of DNA flow cytometry as a screening test for bladder cancer

✍ Ralph W. Devere White; Arline D. Deltch 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

At this present time, we feel that there is no role for DNA flow cytometry (FCM), or indeed DNA studies by any other method, to be used as a screening procedure for patients with no prior history of bladder cancer due to the high false-positive rate found when monitoring exfoliated urothelial cells.